|
|
Volumn 377, Issue 20, 2017, Pages 1996-1997
|
|
Cognitive function in a randomized trial of evolocumab
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EVOLOCUMAB;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PROPROTEIN CONVERTASE 9;
MONOCLONAL ANTIBODY;
PLACEBO;
ATTENTION;
COGNITION;
COGNITION ASSESSMENT;
DEPLETION;
DEPRESSION;
DISEASE ASSOCIATION;
DISORDERS OF HIGHER CEREBRAL FUNCTION;
HUMAN;
LETTER;
MEMORY;
MOOD DISORDER;
PRIORITY JOURNAL;
TOTAL CHOLESTEROL LEVEL;
HYPERCHOLESTEROLEMIA;
ARTICLE;
CHOLESTEROL BLOOD LEVEL;
COGNITIVE FUNCTION TEST;
DRUG USE;
EPISODIC MEMORY;
EXECUTIVE FUNCTION;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
WORKING MEMORY;
ANTIBODIES, MONOCLONAL;
CHOLESTEROL, LDL;
COGNITION;
HUMANS;
HYPERCHOLESTEROLEMIA;
|
|
EID: 85033774526
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1712102 Document Type: Letter |
|
Times cited : (119)
|
|
References (4)
|
